Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial
Ali Salavati, Fenghai Duan, Bradley S. Snyder, Bo Wei, Sina Houshmand, Benjapa Khiewvan, Adam Opanowski, Charles B. Simone, Barry A. Siegel, Mitchell Machtay, Abass Alavi
Dive into the research topics of 'Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial'. Together they form a unique fingerprint.